Stoke Therapeutics, Inc. (STOK) Revenue History
Stoke Therapeutics, Inc. (STOK) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | $12.40M |
| 2023-12-31 | $8.78M |
| 2024-12-31 | $36.55M |
| 2025-12-31 | $184.42M |
How STOK compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| IDYA | IDEAYA Biosciences Inc. | $218.71M |
| RGNX | REGENXBIO Inc. | $170.44M |
| SPRO | Spero Therapeutics Inc. | $66.80M |
| NKTR | Nektar Therapeutics | $55.23M |
| OCUL | Ocular Therapeutix Inc. | $51.95M |
These are five companies in the same sector as STOK with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Stoke Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("STOK", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | STOK | $31.40 | -4.93% | 1.10M |
| 3 | ||||
| 4 | ||||
| 5 |